Alberta, Canada: A study by University of Alberta researcher Scot Simpson has shed light on the use of aspirin as a preventative measure for cardiovascular disease and reoccurrence in patients with diabetes.
The study collected data from clinical trials that looked at whether taking aspirin as a course of treatment would prevent a first or recurrent heart attack or stroke.
Using information from diabetic patients in these studies, Simpson discovered that patients with previous cardiac episodes who were taking a low dose of aspirin daily had very little benefit in terms of prevention of a second heart attack or a decreased risk of mortality.
However, in patients taking higher doses of aspirin, the risk of a repeat heart attack and/or death was significantly lower.
"We took all of the data from 21 studies and focused specifically on diabetic patients who had suffered a previous heart attack or stroke to measure the ability of aspirin to prevent a second event. We found that, if those patients took up to 325 milligrams of aspirin per day, they had a 23 percent lower risk of death," said Simpson.